表紙
市場調查報告書

全球糖尿病性胃輕癱治療市場

Global Market Study on Diabetic Gastroparesis Treatment : Drugs Product Type Segment Expected to Account for Maximum Revenue Share by 2024

出版商 Persistence Market Research 商品編碼 398963
出版日期 內容資訊 英文 209 Pages
商品交期: 2-3個工作天內
價格
全球糖尿病性胃輕癱治療市場 Global Market Study on Diabetic Gastroparesis Treatment : Drugs Product Type Segment Expected to Account for Maximum Revenue Share by 2024
出版日期: 2016年09月20日內容資訊: 英文 209 Pages
簡介

本報告提供全球糖尿病性胃輕癱治療市場相關調查分析,提供您市場概要,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統性資訊。

第1章 摘要整理

第2章 前提條件·簡稱

第3章 調查手法

第4章 糖尿病性胃輕癱治療市場概要

  • 簡介
  • 市場動態
  • 開發平台評估
  • 法規·償付方案
  • 疾病的流行病學:各地區

第5章 全球糖尿病性胃輕癱治療市場預測

  • 市場金額的預測
  • 市場趨勢
  • 各地區的平均價格分析
  • 市場概述

第6章 全球糖尿病性胃輕癱治療市場分析:各產品類型

  • 簡介
  • 市場預測:各產品類型
  • 市場魅力分析:各產品類型
  • 顯著的趨勢

第7章 全球糖尿病性胃輕癱治療市場分析:疾病的各適應症

  • 簡介
  • 市場預測:疾病的各適應症
  • 市場魅力分析:疾病的各適應症
  • 顯著的趨勢

第8章 全球糖尿病性胃輕癱治療市場分析:各銷售管道

  • 簡介
  • 市場預測:各銷售管道

第9章 全球糖尿病性胃輕癱治療市場分析:各地區

  • 簡介
  • 市場預測:各地區
  • 地區的魅力分析

第10章 北美的糖尿病性胃輕癱治療市場分析

  • 簡介
  • 主要的法規
  • 主要趨勢
  • 市場預測
  • 市場魅力分析

第11章 南美的糖尿病性胃輕癱治療市場分析

  • 簡介
  • 主要的法規
  • 主要趨勢
  • 市場預測
  • 市場魅力分析

第12章 歐洲的糖尿病性胃輕癱治療市場分析

  • 簡介
  • 主要的法規
  • 主要趨勢
  • 市場預測
  • 市場魅力分析

第13章 亞太地區的糖尿病性胃輕癱治療市場分析

  • 簡介
  • 主要的法規
  • 主要趨勢
  • 市場預測
  • 市場魅力分析

第14章 中東·非洲的糖尿病性胃輕癱治療市場分析

  • 簡介
  • 主要的法規
  • 主要趨勢
  • 市場預測
  • 市場魅力分析

第15章 競爭情形

  • 競爭儀表板
  • 企業簡介的內容
  • 企業簡介
    • Janssen Global Services, LLC
    • Evoke Pharma
    • Cardinal Health, Inc.
    • Salix Pharmaceuticals, Inc.
    • Alfa Wassermann SPA
    • Abbott Laboratories
    • Medtronic Plc.
    • C. R. Bard, Inc.
    • Rhythm Pharmaceuticals, Inc.
    • Boston Scientific Corporation
    • Kimberly-Clark Corporation
目錄

This Persistence Market Research (PMR) report examines the global diabetic gastroparesis treatment market and identifies trends likely to govern the market during the period 2016-2024. The primary objective of the report is to offer updates and information related to market opportunities in the global diabetic gastroparesis treatment market. The report analyzes the global diabetic gastroparesis treatment market in terms of market value. This report also provides useful information on drugs and surgical treatment products used for patients suffering from diabetic gastroparesis disorder.

To understand and assess opportunities in this market, the report is categorically split into four sections based on product type, disease indication, distribution channel, and region. The report starts with an overview of the global diabetic gastroparesis treatment market along with product categories used to control the symptoms of diabetic gastroparesis disorder such as nausea, vomiting, and abdominal pain. This section also covers the revenue performance of the diabetic gastroparesis treatment market both globally as well as regionally. A detailed analysis of key trends, drivers, and restraints from the supply and demand perspectives are also included. The next few sections analyze the market based on product type, disease indication, distribution channel, and region and present a forecast in terms of value for the period 2016 to 2024.

In the final section of the report, the global diabetic gastroparesis treatment market landscape is included to provide report audiences with a dashboard view based on categories of providers in the global diabetic gastroparesis treatment product portfolio. The report provides insights into key developments and strategies adopted by leading companies operating in this market. Some of the market leaders profiled in the report include Janssen Global Services, LLC, Salix Pharmaceuticals, Inc., Abbott Laboratories, Medtronic, C. R. Bard, Inc., Kimberly-Clark Corporation, Boston Scientific Corporation, Cardinal Health, Inc., Rhythm Pharmaceuticals, Inc., Evoke Pharma, and Alfa Wassermann SPA.

diabetic gastroparesis market report primer

Research Methodology

To arrive at the market size, the report considers revenue from the sales of diabetic gastroparesis products in key markets across five geographies. The forecast presented here assesses the total revenue generated by diabetic gastroparesis drugs and surgical equipment manufacturing companies. The market forecast takes into consideration basic fundamental dynamics of the disease spread, regional epidemiology, and currently available treatment options. Given the characteristics of the market, the report presents triangulated data based on different supply side and demand side analysis as well as market dynamics. The report also considers regulations (particularly pertaining to labeling of drugs and medical device reporting for devices) and government guidelines. Quantification of data has been considered along with provision of quality insights collected directly from the market through discussions with product managers, marketing managers, and other industry experts.

The report also presents Year-on-Year (YoY) growth based on regional market growth analysis in order to understand market predictability and to identify the right opportunities in the global diabetic gastroparesis treatment market. A detailed analysis of all market segments in terms of Basis Point (BPS) helps project individual segments' relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global diabetic gastroparesis treatment market.

Another key feature of this report is the analysis of the global diabetic gastroparesis treatment market by region - which is further segmented on the basis of countries - and highlights revenue forecast in terms of absolute dollar opportunity. Regional trends have been introspected, identified, and applied while forecasting growth rates in the market. Absolute dollar opportunity provided in the report is critical and is expected to help in assessing the level of opportunity that a provider can look to achieve from a sales perspective. Persistence Market Research has also developed a market Attractiveness Index for all segments to help identify real market opportunities.

Table of Contents

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Diabetic Gastroparesis Treatment Market Overview

  • 4.1.Introduction
    • 4.1.1.Diabetic Gastroparesis Treatment Market Definition
    • 4.1.2.Diabetic Gastroparesis Treatment Market Taxonomy
    • 4.1.3.Diabetic Gastroparesis Treatment Market Product Type Overview
    • 4.1.4. Overview
  • 4.2.Diabetic Gastroparesis Treatment Market Dynamics
    • 4.2.1.Drivers
    • 4.2.2.Restraints
    • 4.2.3.Opportunity
    • 4.2.4.Value Chain
  • 4.3.Pipeline Assessment
  • 4.4.Regulations &Reimbursement Scenario
  • 4.5.Disease Epidemiology, By Region

5. Global Diabetic Gastroparesis Treatment Market Forecast

  • 5.1.Market Value (US$ Mn) Forecast
    • 5.1.1.Y-o-Y Growth Projections
    • 5.1.2.Absolute $ Opportunity
  • 5.2.Diabetic Gastroparesis Treatment Market Trends
  • 5.3.Regional Average Pricing Analysis (2015)
  • 5.4.Global Diabetic Gastroparesis Treatment Market Snapshot (2015)
    • 5.4.1.Market Share, By Region
    • 5.4.2.Market Share, By Product Type
    • 5.4.3.Market Share, By Distribution Channel
    • 5.4.4.Market Share, By Disease Indication

6. Global Diabetic Gastroparesis Treatment Market Analysis, By Product Type

  • 6.1.Introduction
    • 6.1.1.Y-o-Y Growth Comparison, By Product Type
    • 6.1.2.Market Share & Basis Point (BPS) Analysis, By Product Type
  • 6.2.Market Forecast, By Product Type
    • 6.2.1.Drugs
      • 6.2.1.1.Absolute $ Opportunity
      • 6.2.1.2.Market Value (US$ Mn) Forecast
      • 6.2.1.3.Gastroprokinetic Agents
      • 6.2.1.4.Antiemetic Agents
      • 6.2.1.5.Botulinum Toxin
    • 6.2.2.Surgical Treatment Products
      • 6.2.2.1.Absolute $ Opportunity
      • 6.2.2.2.Market Value (US$ Mn) Forecast
      • 6.2.2.3.Gastric Electrical Stimulation (GES) Devices
      • 6.2.2.4.Percutaneous Endoscopic Gastrostomy (PEG) Kit
      • 6.2.2.5.Parenteral Nutrition
  • 6.3.Market Attractiveness Analysis, By Product Type
  • 6.4.Prominent Trends

7. Global Diabetic Gastroparesis Treatment Market Analysis, By Disease Indication

  • 7.1.Introduction
    • 7.1.1.Y-o-Y Growth Comparison, By Disease Indication
    • 7.1.2.Market Share & Basis Point (BPS) Analysis, By Disease Indication
  • 7.2.Market Forecast, By Disease Indication
    • 7.2.1.Compensated Gastroparesis
      • 7.2.1.1.Absolute $ Opportunity
      • 7.2.1.2.Market Value (US$ Mn) Forecast
    • 7.2.2.Gastric Failure
      • 7.2.2.1.Absolute $ Opportunity
      • 7.2.2.2.Market Value (US$ Mn) Forecast
  • 7.3.Market Attractiveness Analysis, By Disease Indication
  • 7.4.Prominent Trends

8. Global Diabetic Gastroparesis Treatment Market Analysis, By Distribution Channel

  • 8.1.Introduction
    • 8.1.1.Y-o-Y Growth Comparison, By Distribution Channel
    • 8.1.2.Market Share & Basis Point (BPS) Analysis, By Distribution Channel
  • 8.2.Market Forecast, By Distribution Channel
    • 8.2.1.Hospital Pharmacies
      • 8.2.1.1.Absolute $ Opportunity
      • 8.2.1.2.Market Value (US$ Mn) Forecast
    • 8.2.2.Private Clinics
      • 8.2.2.1.Absolute $ Opportunity
      • 8.2.2.2.Market Value (US$ Mn) Forecast
    • 8.2.3.Drug Stores
      • 8.2.3.1.Absolute $ Opportunity
      • 8.2.3.2.Market Value (US$ Mn) Forecast
    • 8.2.4.Retail Pharmacies
      • 8.2.4.1.Absolute $ Opportunity
      • 8.2.4.2.Market Value (US$ Mn) Forecast
    • 8.2.5.E-commerce
      • 8.2.5.1.Absolute $ Opportunity
      • 8.2.5.2.Market Value (US$ Mn) Forecast

9. Global Diabetic Gastroparesis Treatment Market Analysis, By Region

  • 9.1.Introduction
    • 9.1.1.Y-o-Y Growth Projections, By Region
    • 9.1.2.Market Share & Basis Point (BPS) Analysis, By Region
  • 9.2.Market Forecast, By Region
    • 9.2.1.North America Market Value (US$ Mn) Forecast
    • 9.2.2.Latin AmericaMarket Value (US$ Mn) Forecast
    • 9.2.3.Europe Market Value (US$ Mn) Forecast
    • 9.2.4.APAC Market Value (US$ Mn) Forecast
    • 9.2.5.MEA Market Value (US$ Mn) Forecast
  • 9.3.Regional Attractiveness Analysis

10. North America Diabetic Gastroparesis Treatment Market Analysis

  • 10.1. Introduction
    • 10.1.1. Y-o-Y Growth Projections, By Country
    • 10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
  • 10.2. Key Regulations
  • 10.3. Key Trends
  • 10.4. North America Market Forecast
    • 10.4.1. Market Value (US$ Mn) Forecast, By Country
      • 10.4.1.1.U.S. Absolute $ Opportunity
      • 10.4.1.2.Canada Absolute $ Opportunity
    • 10.4.2. Market Value (US$ Mn) Forecast, By Product Type
      • 10.4.2.1.Drugs
        • 10.4.2.1.1. Gastroprokinetic Agents
        • 10.4.2.1.2. Antiemetic Agents
        • 10.4.2.1.3. Botulinum Toxin
      • 10.4.2.2.Surgical Treatment Products
        • 10.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
        • 10.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
        • 10.4.2.2.3. Parenteral Nutrition
    • 10.4.3. Market Value (US$ Mn) Forecast, By Disease Indication
      • 10.4.3.1.Compensated Gastroparesis
      • 10.4.3.2.Gastric Failure
    • 10.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
      • 10.4.4.1.Hospital Pharmacies
      • 10.4.4.2.Private Clinics
      • 10.4.4.3.Drug Stores
      • 10.4.4.4. Retail Pharmacies
      • 10.4.4.5. E-commerce
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Product Type
    • 10.5.3. By Distribution Channel
    • 10.5.4. By Disease Indication

11. Latin AmericaDiabetic Gastroparesis Treatment Market Analysis

  • 11.1. Introduction
    • 11.1.1. Y-o-Y Growth Projections, By Country
    • 11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
  • 11.2. Key Regulations
  • 11.3. Key Trends
  • 11.4. Latin America Market Forecast
    • 11.4.1. Market Value (US$ Mn) Forecast, By Country
      • 11.4.1.1.Brazil Absolute $ Opportunity
      • 11.4.1.2.Mexico Absolute $ Opportunity
      • 11.4.1.3.Rest of Latin America Absolute $ Opportunity
    • 11.4.2. Market Value (US$ Mn) Forecast, By Product Type
      • 11.4.2.1.Drugs
        • 11.4.2.1.1. Gastroprokinetic Agents
        • 11.4.2.1.2. Antiemetic Agents
        • 11.4.2.1.3. Botulinum Toxin
      • 11.4.2.2.Surgical Treatment Products
        • 11.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
        • 11.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
        • 11.4.2.2.3. Parenteral Nutrition
    • 11.4.3. Market Value (US$ Mn) Forecast, By Disease Indication
      • 11.4.3.1.Compensated Gastroparesis
      • 11.4.3.2.Gastric Failure
    • 11.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
      • 11.4.4.1.Hospital Pharmacies
      • 11.4.4.2.Private Clinics
      • 11.4.4.3.Drug Stores
      • 11.4.4.4. Retail Pharmacies
      • 11.4.4.5.E-commerce
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Distribution Channel
    • 11.5.4. By Disease Indication

12. Europe Diabetic Gastroparesis Treatment Market Analysis

  • 12.1. Introduction
    • 12.1.1. Y-o-Y Growth Projections, By Country
    • 12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
  • 12.2. Key Regulations
  • 12.3. Key Trends
  • 12.4. Europe Market Forecast
    • 12.4.1. Market Value (US$ Mn) Forecast, By Country
      • 12.4.1.1.EU5 Absolute $ Opportunity
      • 12.4.1.2.Russia Absolute $ Opportunity
      • 12.4.1.3.Rest of Europe Absolute $ Opportunity
    • 12.4.2. Market Value (US$ Mn) Forecast, By Product Type
      • 12.4.2.1.Drugs
        • 12.4.2.1.1. Gastroprokinetic Agents
        • 12.4.2.1.2. Antiemetic Agents
        • 12.4.2.1.3. Botulinum Toxin
      • 12.4.2.2.Surgical Treatment Products
        • 12.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
        • 12.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
        • 12.4.2.2.3. Parenteral Nutrition
    • 12.4.3. Market Value (US$ Mn) Forecast, By Disease Indication
      • 12.4.3.1.Compensated Gastroparesis
      • 12.4.3.2.Gastric Failure
    • 12.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
      • 12.4.4.1.Hospital Pharmacies
      • 12.4.4.2.Private Clinics
      • 12.4.4.3.Drug Stores
      • 12.4.4.4. Retail Pharmacies
      • 12.4.4.5. E-commerce
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Distribution Channel
    • 12.5.4. By Disease Indication

13. APAC Diabetic Gastroparesis Treatment Market Analysis

  • 13.1. Introduction
    • 13.1.1. Y-o-Y Growth Projections, By Country
    • 13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
  • 13.2. Key Regulations
  • 13.3. Key Trends
  • 13.4. APAC Market Forecast
    • 13.4.1. Market Value (US$ Mn) Forecast, By Country
      • 13.4.1.1.China Absolute $ Opportunity
      • 13.4.1.2.Japan Absolute $ Opportunity
      • 13.4.1.3.Australia & New Zealand Absolute $ Opportunity
      • 13.4.1.4.ASEANAbsolute $ Opportunity
      • 13.4.1.5.Rest of APAC Absolute $ Opportunity
    • 13.4.2. Market Value (US$ Mn) Forecast, By Product Type
      • 13.4.2.1.Drugs
        • 13.4.2.1.1. Gastroprokinetic Agents
        • 13.4.2.1.2. Antiemetic Agents
        • 13.4.2.1.3. Botulinum Toxin
      • 13.4.2.2.Surgical Treatment Products
        • 13.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
        • 13.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
        • 13.4.2.2.3. Parenteral Nutrition
    • 13.4.3. Market Value (US$ Mn) Forecast, By Disease Indication
      • 13.4.3.1.Compensated Gastroparesis
      • 13.4.3.2.Gastric Failure
    • 13.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
      • 13.4.4.1.Hospital Pharmacies
      • 13.4.4.2.Private Clinics
      • 13.4.4.3.Drug Stores
      • 13.4.4.4. Retail Pharmacies
      • 13.4.4.5. E-commerce
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Distribution Channel
    • 13.5.4. By Disease Indication

14. MEA Diabetic Gastroparesis Treatment Market Analysis

  • 14.1. Introduction
    • 14.1.1. Y-o-Y Growth Projections, By Country
    • 14.1.2. Market Share & Basis Point (BPS) Analysis, By Country
  • 14.2. Key Regulations
  • 14.3. Key Trends
  • 14.4. MEA Market Forecast
    • 14.4.1. Market Value (US$ Mn) Forecast, By Country
      • 14.4.1.1.GCC Countries Absolute $ Opportunity
      • 14.4.1.2.South Africa Absolute $ Opportunity
      • 14.4.1.3.Rest of MEA Absolute $ Opportunity
    • 14.4.2. Market Value (US$ Mn) Forecast, By Product Type
      • 14.4.2.1.Drugs
        • 14.4.2.1.1. Gastroprokinetic Agents
        • 14.4.2.1.2. Antiemetic Agents
        • 14.4.2.1.3. Botulinum Toxin
      • 14.4.2.2.Surgical Treatment Products
        • 14.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
        • 14.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
        • 14.4.2.2.3. Parenteral Nutrition
    • 14.4.3. Market Value (US$ Mn) Forecast, By Disease Indication
      • 14.4.3.1.Compensated Gastroparesis
      • 14.4.3.2.Gastric Failure
    • 14.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
      • 14.4.4.1.Hospital Pharmacies
      • 14.4.4.2.Private Clinics
      • 14.4.4.3.Drug Stores
      • 14.4.4.4. Retail Pharmacies
      • 14.4.4.5. E-commerce
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Distribution Channel
    • 14.5.4. By Disease Indication

15.Competition Landscape

  • 15.1.Competition Dashboard
  • 15.2.Company Profiles Inclusions
    • 15.2.1.Revenue
    • 15.2.2.Products/Brand Offerings
    • 15.2.3.Key developments
    • 15.2.4.SWOT Analysis
  • 15.3.Company Profiles
    • 15.3.1.Janssen Global Services, LLC
    • 15.3.2.Evoke Pharma
    • 15.3.3.Cardinal Health, Inc.
    • 15.3.4.Salix Pharmaceuticals, Inc.
    • 15.3.5.Alfa Wassermann SPA
    • 15.3.6.Abbott Laboratories
    • 15.3.7.Medtronic Plc.
    • 15.3.8.C. R. Bard, Inc.
    • 15.3.9.Rhythm Pharmaceuticals, Inc.
    • 15.3.10.Boston Scientific Corporation
    • 15.3.11.Kimberly-Clark Corporation

List of Tables

  • Table 01 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 02 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 03 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)
  • Table 04 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Region (US$ Mn) (2016-2024)
  • Table 05 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016-2024)
  • Table 06 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 07 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 08 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)
  • Table 09 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016-2024)
  • Table 10 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 11 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 12 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)
  • Table 13 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016-2024)
  • Table 14 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 15 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 16 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)
  • Table 17 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016-2024)
  • Table 18 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 19 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 20 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)
  • Table 21 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016-2024)
  • Table 22 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016-2024)
  • Table 23 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016-2024)
  • Table 24 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016-2024)

List of Figures

  • Figure 01: Global Diabetic Gastroparesis Treatment Market, 2015
  • Figure 02: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2024
  • Figure 03: Global Diabetic Gastroparesis Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 04: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Product Type, 2016 & 2024
  • Figure 05: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Product Type, 2016-2024
  • Figure 06: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Drug Segment
  • Figure 07: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Drug Segment, 2016-2024
  • Figure 08: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Botulinum Toxin Sub-segment
  • Figure 09: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Gastroprokinetic Agents Sub-segment
  • Figure 10: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Antiemetic Agents Sub-segment
  • Figure 11: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Surgical Treatment Products Segment
  • Figure 12: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Surgical Treatment Products Segment, 2016-2024
  • Figure 13: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Parenteral Nutrition Sub-segment
  • Figure 14: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Gastric Electrical Stimulation (GES) Device Sub-segment
  • Figure 15: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Percutaneous Endoscopic Gastrostomy (PEG) Kit Sub-segment
  • Figure 16: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 17: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Disease Indication, 2016 & 2024
  • Figure 18: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Disease Indication, 2016-2024
  • Figure 19: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Compensated Gastroparesis Segment
  • Figure 20: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Compensated Gastroparesis Segment, 2016-2024
  • Figure 21: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Gastric Failure Segment
  • Figure 22: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Gastric Failure Segment, 2016-2024
  • Figure 23: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 24: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
  • Figure 25: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Distribution Channel, 2016-2024
  • Figure 26: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Hospital Pharmacies Segment
  • Figure 27: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Hospital Pharmacies Segment, 2016-2024
  • Figure 28: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Private Clinics Segment
  • Figure 29: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Private Clinics Segment, 2016-2024
  • Figure 30: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Drug Stores Segment
  • Figure 31: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Drug Stores Segment, 2016-2024
  • Figure 32: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By Retail Pharmacies Segment
  • Figure 33: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Retail Pharmacies Segment, 2016-2024
  • Figure 34: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024) By E-commerce Segment
  • Figure 35: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By E-commerce Segment, 2016-2024
  • Figure 36: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 37: Europe Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 38: North America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 39: Latin America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 40: APAC Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 41: MEA Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 42: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Region, 2016-2024
  • Figure 43: North America Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 44: North America Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 45: The U.S Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 46: The U.S Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 47: Canada Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 48: Canada Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 49: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016-2024
  • Figure 50: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 51: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 52: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 53: Latin America Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 54: Latin America Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 55: Brazil Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 56: Brazil Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 57: Mexico Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 58: Mexico Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 59: Rest of Latin America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 60: Rest of Latin America Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 61: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016-2024
  • Figure 62: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 63: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 64: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 65: Europe Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 66: Europe Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 67: EU5 Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 68: EU5 Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 69: Russia Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 70: Russia Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 71: Rest of Europe Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 72: Rest of Europe Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 73: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016-2024
  • Figure 74: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 75: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 76: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 77: APAC Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 78: APAC Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 79: China Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 80: China Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 81: Japan Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 82: Japan Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 83: Australia & New Zealand Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 84: Australia & New Zealand Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 85: ASEAN Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 86: ASEAN Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 87: Rest of APAC Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 88: Rest of APAC Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 89: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016-2024
  • Figure 90: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 91: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 92: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 93: MEA Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 94: MEA Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 95: GCC Countries Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 96: GCC Countries Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 97: South Africa Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 98: South Africa Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 99: Rest of MEA Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 100: Rest of MEA Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016-2024
  • Figure 101: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016-2024
  • Figure 102: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016-2024
  • Figure 103: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016-2024
  • Figure 104: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016-2024